[Association of TNNT2 gene mutations with idiopathic dilated cardiomyopathy in a Chengdu population]

Bin Chen1, Li Rao, Bin Zhou

  • 1Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China.

Insights

The cardiac troponin T gene (TNNT2) showed no mutations in patients with idiopathic dilated cardiomyopathy (IDCM) in Chengdu. Identified TNNT2 polymorphisms are not linked to IDCM development.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Context:

  • Idiopathic dilated cardiomyopathy (IDCM) is a significant cause of heart failure.
  • The role of genetic factors, specifically the cardiac troponin T gene (TNNT2), in IDCM pathogenesis requires further investigation.
  • Previous studies have suggested TNNT2 as a potential virulence gene, but evidence in specific populations is limited.

Purpose:

  • To investigate the association between TNNT2 gene mutations and idiopathic dilated cardiomyopathy (IDCM) in a Chengdu population.
  • To screen for specific TNNT2 mutations (Arg131Trp, Arg141Trp, Arg205Leu, deltaLys210, Asp270Asn) in IDCM patients and healthy controls.
  • To identify potential genetic variants contributing to IDCM in the Chinese Han population.

Summary:

  • DNA analysis of 96 IDCM patients and 110 healthy controls from Chengdu was performed.
  • Polymerase chain reaction-single strand conformation polymorphisms (PCR-SSCP) and nucleotide sequencing were used to screen for TNNT2 mutations.
  • No mutations in the TNNT2 gene were detected in either IDCM patients or healthy individuals. Two polymorphisms, G9005C and C13350T, were identified but found to be unrelated to IDCM.

Impact:

  • This study rules out TNNT2 mutations as a cause of IDCM in the studied Chengdu population.
  • The findings contribute to understanding the genetic landscape of IDCM.
  • Further research into other genetic factors and non-genetic influences is warranted for IDCM etiology.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...